Weight loss drug trial aims to curb cannabis cravings
NCT ID NCT07265752
Summary
This small pilot study is testing whether tirzepatide, a medication currently used for diabetes and weight loss, can help people with severe cannabis addiction. Six participants will receive either the drug or a placebo injection in a random order to see if it reduces their cravings when shown cannabis-related images. The main goal is to measure changes in craving intensity, while also tracking weight, blood sugar, mood, and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.